SeaCrest Wealth Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.76M | Sell |
21,502
-13,066
| -38% | -$1.53M | 0.31% | 59 |
|
|
2026
Q1 | $4.16M | Sell |
34,568
-1,420
| -4% | -$164K | 0.44% | 37 |
|
|
2025
Q4 | $3.91M | Buy |
35,988
+11,454
| +47% | +$1.08M | 0.4% | 41 |
|
|
2025
Q3 | $2.12M | Sell |
24,534
-3,168
| -11% | -$261K | 0.22% | 82 |
|
|
2025
Q2 | $2.19M | Sell |
27,702
-2,425
| -8% | -$193K | 0.24% | 76 |
|
|
2025
Q1 | $2.7M | Sell |
30,127
-3,993
| -12% | -$373K | 0.31% | 55 |
|
|
2024
Q4 | $3.39M | Sell |
34,120
-3,506
| -9% | -$361K | 0.36% | 41 |
|
|
2024
Q3 | $4.27M | Sell |
37,626
-772
| -2% | -$91.7K | 0.46% | 33 |
|
|
2024
Q2 | $4.75M | Sell |
38,398
-658
| -2% | -$84.8K | 0.54% | 24 |
|
|
2024
Q1 | $5.15M | Sell |
39,056
-19,420
| -33% | -$2.39M | 0.63% | 22 |
|
|
2023
Q4 | $6.85M | Sell |
58,476
-5,081
| -8% | -$527K | 0.85% | 18 |
|
|
2023
Q3 | $6.54M | Sell |
63,557
-1,564
| -2% | -$169K | 0.85% | 17 |
|
|
2023
Q2 | $7.51M | Buy |
65,121
+4,584
| +8% | +$520K | 0.95% | 13 |
|
|
2023
Q1 | $6.44M | Buy |
60,537
+1,073
| +2% | +$116K | 0.87% | 16 |
|
|
2022
Q4 | $6.6M | Sell |
59,464
-4,078
| -6% | -$417K | 0.95% | 14 |
|
|
2022
Q3 | $5.47M | Sell |
63,542
-1,063
| -2% | -$94.9K | 0.83% | 18 |
|
|
2022
Q2 | $5.89M | Buy |
64,605
+1,375
| +2% | +$122K | 0.74% | 16 |
|
|
2022
Q1 | $5.19M | Buy |
63,230
+2,411
| +4% | +$190K | 0.6% | 27 |
|
|
2021
Q4 | $4.66M | Buy |
60,819
+7,029
| +13% | +$560K | 0.51% | 33 |
|
|
2021
Q3 | $4.04M | Buy |
53,790
+1,499
| +3% | +$114K | 0.49% | 39 |
|
|
2021
Q2 | $4.07M | Buy |
52,291
+6,229
| +14% | +$463K | 0.49% | 38 |
|
|
2021
Q1 | $3.39M | Sell |
46,062
-5,566
| -11% | -$411K | 0.45% | 48 |
|
|
2020
Q4 | $4.03M | Buy |
51,628
+517
| +1% | +$39.5K | 0.57% | 38 |
|
|
2020
Q3 | $4.04M | Buy |
51,111
+1,059
| +2% | +$82.9K | 0.65% | 29 |
|
|
2020
Q2 | $3.69M | Buy |
50,052
+1,120
| +2% | +$84.3K | 0.64% | 29 |
|
|
2020
Q1 | $3.59M | Buy |
48,932
+2,182
| +5% | +$171K | 0.77% | 24 |
|
|
2019
Q4 | $4.06M | Buy |
46,750
+2,727
| +6% | +$224K | 0.68% | 28 |
|
|
2019
Q3 | $3.54M | Buy |
44,023
+1,387
| +3% | +$111K | 0.66% | 29 |
|
|
2019
Q2 | $3.41M | Buy |
42,636
+134
| +0.3% | +$10.3K | 0.69% | 28 |
|
|
2019
Q1 | $3.37M | Buy |
42,502
+329
| +0.8% | +$24.6K | 0.58% | 32 |
|
|
2018
Q4 | $3.08M | Sell |
42,173
-1,801
| -4% | -$127K | 0.63% | 27 |
|
|
2018
Q3 | $2.98M | Sell |
43,974
-2,577
| -6% | -$164K | 0.5% | 36 |
|
|
2018
Q2 | $2.7M | Sell |
46,551
-1,132
| -2% | -$63.9K | 0.49% | 37 |
|
|
2018
Q1 | $2.48M | Buy |
47,683
+215
| +0.5% | +$11.6K | 0.45% | 46 |
|
|
2017
Q4 | $2.55M | Buy |
+47,468
| New | +$2.63M | 0.47% | 43 |
|
Other funds holding MRK
ECSS
ATO
SeaCrest Wealth Management's MRK Position: Q2 2026 in Review
SeaCrest Wealth Management reduced its Merck (MRK) stake by 38% in Q2 2026, selling an estimated $1.53M and leaving 21,502 shares worth $2.76M. The position accounts for 0.31% of the portfolio, ranked #59.
SeaCrest Wealth Management first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $7.51M in Q2 2023. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- SeaCrest Wealth Management held 21,502 shares of Merck worth $2.76M as of Q2 2026.
- SeaCrest Wealth Management sold 13,066 Merck shares in Q2 2026, an estimated $1.53M.
- Merck made up 0.31% of SeaCrest Wealth Management's portfolio in Q2 2026, its #59 holding.
- SeaCrest Wealth Management first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- SeaCrest Wealth Management's Merck position peaked at $7.51M in Q2 2023.
- 1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on SeaCrest Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.